Allergan Inc.

NYS : AGN
Pharmaceuticals
Irvine CA
2013 Revenue (US$ Millions)$6,300
2012 Revenue (US$ Millions)$5,806
Revenue Growth (%)8.51%
Net Income (US$ Millions)$985
Common Shares Outstanding (Millions)$298
Earnings Per Share (US$)$3.26
Price To Earnings Ratio116.17
Total Equity (US$ Millions)$6,463
Profit Margin (%)15.64%
Return On Equity (%)16.88%
Long Term Debt (US$ Millions)$2,098
Debt To Equity Ratio (%)0.32%
Market Capitalization (US$ Millions)$33,058
Total Assets (US$ Millions)$10,574
Return on Assets (%)10.73
Current Assets (US$ Millions)$5,320
Inventories (US$ Millions)$285
Current Liabilities (US$ Millions)$1,244
Cost of Goods Sold (US$ Millions)$796
Asset Turnover0.6
Inventory Turnover2.8
ExchangeNYS